Assessing the comparative value of sedatives in the intensive care unit

Crit Care Med. 2010 Feb;38(2):709-11. doi: 10.1097/CCM.0b013e3181bfeaf7.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Cost Savings / economics
  • Cost-Benefit Analysis
  • Critical Care / economics*
  • Critical Care / methods
  • Dexmedetomidine / adverse effects
  • Dexmedetomidine / economics*
  • Dexmedetomidine / therapeutic use
  • Humans
  • Hypnotics and Sedatives / adverse effects
  • Hypnotics and Sedatives / economics*
  • Hypnotics and Sedatives / therapeutic use
  • Intensive Care Units / economics
  • Long-Term Care / economics
  • Long-Term Care / methods
  • Midazolam / adverse effects
  • Midazolam / economics*
  • Midazolam / therapeutic use
  • Respiration, Artificial / economics
  • Respiration, Artificial / methods

Substances

  • Hypnotics and Sedatives
  • Dexmedetomidine
  • Midazolam